Bone marrow link: Amsterdam UMC study suggests anti‑inflammatory effects of semaglutideSemaglutide, the GLP-1 receptor agonist known as Ozempic and Wegovy, is associated with fewer inflammatory monocytes and reduced inflammatory activity in the bone marrow of people with type 2 diabetes. Researchers from Amsterdam UMC and Amsterdam Cardiovascular Sciences report this in an exploratory first-in-human study published in the European Heart Journal, offering a potential explanation for the cardiovascular benefits of GLP-1 therapies.
Postdoc appreciation week: Luuk Hopman in the spotlightDuring National Postdoc Appreciation Week, we are excited to shine a spotlight on the postdoctoral researchers at Amsterdam Cardiovascular Sciences. Today in the spotlight: Luuk Hopman!
